Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001410939-22-000152
Filing Date
2022-12-29
Accepted
2022-12-29 16:50:55
Documents
1
Period of Report
2022-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167235064050943.html 4  
1 FORM 4 wf-form4_167235064050943.xml 4 3574
  Complete submission text file 0001410939-22-000152.txt   4970
Mailing Address 3 TIMES SQAURE, 12TH FLOOR NEW YORK NY 10036
Business Address
SBLENDORIO GLENN (Reporting) CIK: 0001277478 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36080 | Film No.: 221499340

Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Issuer) CIK: 0001410939 (see all company filings)

EIN.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations